| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
August 2011 - 54 products |
|
L | | IP | CI | | Atorva Viatris 10 mg | 30 | 13.07 | 30.60 | 10 % | | Coated tablets: Atorvastatinum 10 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Atorva Viatris 10 mg | 100 | 42.99 | 63.05 | 10 % | | Coated tablets: Atorvastatinum 10 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Atorva Viatris 20 mg | 30 | 13.03 | 30.55 | 10 % | | Coated tablets: Atorvastatinum 20 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Atorva Viatris 20 mg | 100 | 42.88 | 62.90 | 10 % | | Coated tablets: Atorvastatinum 20 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Atorva Viatris 40 mg | 30 | 13.03 | 30.55 | 10 % | | Coated tablets: Atorvastatinum 40 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Atorva Viatris 40 mg | 100 | 42.88 | 62.90 | 10 % | | Coated tablets: Atorvastatinum 40 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Atorva Viatris 80 mg | 30 | 13.07 | 30.60 | 10 % | | Coated tablets: Atorvastatinum 80 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Atorva Viatris 80 mg | 100 | 42.99 | 63.05 | 10 % | | Coated tablets: Atorvastatinum 80 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 500mg | 100 | PR | PR | k.A. | | Coated tablets: Levetiracetamum 500 mg | Helvepharm AG | B | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 500mg | 200 | PR | PR | k.A. | | Coated tablets: Levetiracetamum 500 mg | Helvepharm AG | B | FB | | G |  |
L | | IP | CI | | Vascord HCT 20/5/12.5mg | 28 Tablet(s) | 17.51 | 35.40 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 20/5/12.5mg | 98 Tablet(s) | 50.01 | 70.55 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/5/12.5mg | 28 Tablet(s) | 21.66 | 39.90 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/5/12.5mg | 98 Tablet(s) | 62.32 | 83.85 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/10/12.5mg | 28 Tablet(s) | 22.58 | 40.90 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/10/12.5mg | 98 Tablet(s) | 68.39 | 90.45 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/5/25mg | 28 Tablet(s) | 21.66 | 39.90 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/5/25mg | 98 Tablet(s) | 62.32 | 83.85 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/10/25mg | 28 Tablet(s) | 22.58 | 40.90 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Vascord HCT 40/10/25mg | 98 Tablet(s) | 68.39 | 90.45 | 10 % | | Coated tablets: 3 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 250mg | 30 | 8.41 | 25.55 | 10 % | | Coated tablets: Levetiracetamum 250 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 500mg | 20 | 9.80 | 27.05 | 10 % | | Coated tablets: Levetiracetamum 500 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 500mg | 100 | 45.03 | 65.40 | 10 % | | Coated tablets: Levetiracetamum 500 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 500mg | 200 | 88.86 | 113.05 | 10 % | | Coated tablets: Levetiracetamum 500 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 1000mg | 30 | 27.61 | 46.45 | 10 % | | Coated tablets: Levetiracetamum 1000 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 1000mg | 100 | 88.12 | 112.25 | 10 % | | Coated tablets: Levetiracetamum 1000 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Levetiracetam Zentiva 1000mg | 200 | 172.82 | 204.35 | 10 % | | Coated tablets: Levetiracetamum 1000 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Mirtazapin Zentiva 30 mg | 10 | 6.65 | 16.45 | 10 % | | Coated tablets: Mirtazapinum 30 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Mirtazapin Zentiva 30 mg | 30 | 17.50 | 35.45 | 10 % | | Coated tablets: Mirtazapinum 30 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Mirtazapin Zentiva 30 mg | 100 | 54.80 | 75.95 | 10 % | | Coated tablets: Mirtazapinum 30 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Mirtazapin Zentiva 45 mg | 30 | 25.60 | 44.25 | 10 % | | Coated tablets: Mirtazapinum 45 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Mirtazapin Zentiva 45 mg | 100 | 72.60 | 95.35 | 10 % | | Coated tablets: Mirtazapinum 45 mg | Helvepharm AG | ● B / SL / SG | FB | | G |  |
| | IP | CI | | Valsartan Zentiva 80 mg | 28 | 6.60 | 23.75 | 20 % | | Coated tablets: Valsartanum 80 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Valsartan Zentiva 80 mg | 98 | 32.01 | 51.15 | 20 % | | Coated tablets: Valsartanum 80 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Valsartan Zentiva 160 mg | 28 | 9.24 | 26.55 | 20 % | | Coated tablets: Valsartanum 160 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Valsartan Zentiva 160 mg | 98 | 42.11 | 62.10 | 20 % | | Coated tablets: Valsartanum 160 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Zabak | 5 ml | 8.94 | 26.15 | 10 % | | Eye drops: Ketotifenum | THEA Pharma S.A. | B / SL | FB | | G |  |
| | IP | CI | | Insulin Lilly Huminsulin Basal KwikPen stylo prérempli | 5 x 3 ml | 31.47 | 50.65 | 10 % | | Injection suspension: Insulinum Humanum adnr Isophanum 100 UI | Eli Lilly (Suisse) SA | B / SL | FB | | G |  |
L | | IP | CI | | VPRIV 400 U | Durchstechflasche(n) | 1957.79 | 2145.65 | 10 % | | Lyophilisate: Velaglucerasum Alfa 400 U | Takeda Pharma AG | B / SL | FB | | G |  |
| | IP | CI | PP | Eliquis 2.5 mg | 20 Tablet(s) | 20.91 | 39.15 | 10 % | | Coated tablets: Apixabanum 2.5 mg | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
| | IP | CI | PP | Eliquis 2.5 mg | 56 | 58.57 | 80.10 | 10 % | | Coated tablets: Apixabanum 2.5 mg | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
| | IP | CI | PP | Eliquis 2.5 mg | 100 Tablet(s) | 104.57 | 130.15 | 10 % | | Coated tablets: Apixabanum 2.5 mg | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
| | IP | CI | PP | Eliquis 2.5 mg | 168 | 175.71 | 207.50 | 10 % | | Coated tablets: Apixabanum 2.5 mg | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
| | IP | CI | PP | Eliquis 5 mg | 56 Tablet(s) | 58.57 | 80.10 | 10 % | | Coated tablets: Apixabanum 5 mg | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
| | IP | CI | PP | Eliquis 5 mg | 100 Tablet(s) | 104.57 | 130.15 | 10 % | | Coated tablets: Apixabanum 5 mg | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
| | IP | CI | PP | Eliquis 5 mg | 168 Tablet(s) | 175.71 | 207.50 | 10 % | | Coated tablets: Apixabanum 5 mg | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
L | | IP | CI | | Lodotra 1 mg | 30 Tablet(s) | 18.16 | 36.15 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Prednisonum 1 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
L | | IP | CI | | Lodotra 1 mg | 100 Tablet(s) | 60.52 | 82.25 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Prednisonum 1 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
L | | IP | CI | | Lodotra 2 mg | 30 Tablet(s) | 18.51 | 36.55 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Prednisonum 2 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
L | | IP | CI | | Lodotra 2 mg | 100 Tablet(s) | 61.69 | 83.50 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Prednisonum 2 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
L | | IP | CI | | Lodotra 5 mg | 30 Tablet(s) | 19.33 | 37.45 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Prednisonum 5 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
L | | IP | CI | | Lodotra 5 mg | 100 Tablet(s) | 64.44 | 86.50 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Prednisonum 5 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
| | IP | CI | CM | Dismenol forte 400 | 10 | PR | PR | k.A. | | Coated tablets: Ibuprofenum 400 mg | Merz Pharma (Schweiz) AG | D | FB | | G |  |
| | IP | CI | | Valsartan Zentiva 40 mg | 28 | PR | PR | k.A. | | Coated tablets: Valsartanum 40 mg | Helvepharm AG | B | FB | | G |  |